| Product Code: ETC7652366 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Israel Gastroesophageal Reflux Disease (GERD) market is witnessing steady growth driven by the increasing prevalence of GERD among the population. Factors such as changing dietary habits, obesity, and lifestyle choices contribute to the rising incidence of GERD in Israel. The market is characterized by a range of treatment options including medications, lifestyle modifications, and surgical interventions. Proton pump inhibitors (PPIs) are the most commonly prescribed medications for GERD management in Israel. The market is also witnessing a growing trend towards minimally invasive surgical procedures for GERD treatment. Key players in the Israel GERD market include pharmaceutical companies, medical device manufacturers, and healthcare providers, all working towards providing effective and innovative solutions to address the needs of GERD patients in the country.
The Israel Gastroesophageal Reflux Disease (GERD) market is witnessing a growing demand for minimally invasive procedures such as endoluminal fundoplication and transoral incisionless fundoplication as alternatives to traditional surgical options. The market is also seeing an increased focus on advanced diagnostic technologies like pH monitoring and impedance testing for accurate GERD diagnosis and treatment planning. Additionally, there is a rising interest in developing innovative pharmaceutical therapies and biologics targeting specific pathways involved in GERD pathophysiology. Opportunities exist for market players to invest in research and development of novel treatment modalities, expand their product portfolios, and collaborate with healthcare providers to enhance patient outcomes and quality of care in the Israel GERD market.
In the Israel Gastroesophageal Reflux Disease (GERD) market, challenges include the increasing prevalence of GERD due to lifestyle factors, such as dietary habits and obesity, which is driving up healthcare costs. Additionally, there is a lack of awareness about the condition among the general population, leading to underdiagnosis and undertreatment of GERD. Limited access to specialized healthcare services and diagnostic tools for accurate diagnosis further complicates the management of GERD in Israel. Furthermore, the competitive landscape among pharmaceutical companies offering treatment options for GERD adds complexity to the market, making it challenging for healthcare providers to navigate the available treatment choices. Overall, addressing these challenges requires a multi-faceted approach involving education, improved access to healthcare services, and collaboration among stakeholders in the healthcare sector.
The Israel Gastroesophageal Reflux Disease (GERD) market is primarily driven by the increasing prevalence of GERD among the population, which is attributed to factors such as unhealthy dietary habits, obesity, and lifestyle changes. Additionally, the rising awareness about the importance of early diagnosis and treatment of GERD is fueling the demand for related products and services in the market. Technological advancements in diagnostic tools and treatment options, as well as the growing geriatric population prone to GERD, are also significant drivers of market growth. Moreover, the presence of key market players investing in research and development activities to introduce innovative therapies and medications further contributes to the expansion of the GERD market in Israel.
Government policies related to the Israel Gastroesophageal Reflux Disease (GERD) market focus on ensuring access to effective treatment options for patients while managing healthcare costs. The Israeli government supports the inclusion of proton pump inhibitors (PPIs) and other medications for GERD in the national health insurance basket, making them more affordable and accessible to the population. Additionally, there are regulations in place to promote the use of generic medications to further reduce healthcare expenditures. The government also emphasizes preventive measures and public health campaigns to raise awareness about GERD risk factors and encourage healthy lifestyle choices. Overall, the policies aim to improve the quality of care for GERD patients, enhance healthcare system sustainability, and promote population health in Israel.
The Israel Gastroesophageal Reflux Disease (GERD) market is expected to witness steady growth in the coming years due to the increasing prevalence of GERD among the population. Factors such as changes in lifestyle, unhealthy dietary habits, and rising obesity rates are contributing to the higher incidence of GERD in Israel. Furthermore, the growing awareness about the available treatment options, advancements in diagnostic techniques, and the introduction of innovative therapies are likely to drive market growth. The market is also expected to benefit from the expanding healthcare infrastructure, improving access to healthcare services, and the rising adoption of minimally invasive procedures for GERD treatment. Overall, the Israel GERD market is poised for growth, offering opportunities for market players to develop and introduce novel solutions to address the unmet needs of patients.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Gastroesophageal Reflux Disease Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Gastroesophageal Reflux Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Gastroesophageal Reflux Disease Market - Industry Life Cycle |
3.4 Israel Gastroesophageal Reflux Disease Market - Porter's Five Forces |
3.5 Israel Gastroesophageal Reflux Disease Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Israel Gastroesophageal Reflux Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Gastroesophageal Reflux Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gastroesophageal reflux disease (GERD) in Israel |
4.2.2 Growing awareness and diagnosis rates of GERD among the population |
4.2.3 Technological advancements in diagnostic and treatment options for GERD patients |
4.3 Market Restraints |
4.3.1 High cost associated with GERD treatment and management |
4.3.2 Limited access to specialized healthcare facilities for GERD patients in certain regions of Israel |
4.3.3 Risk of side effects and complications from long-term use of GERD medications |
5 Israel Gastroesophageal Reflux Disease Market Trends |
6 Israel Gastroesophageal Reflux Disease Market, By Types |
6.1 Israel Gastroesophageal Reflux Disease Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Gastroesophageal Reflux Disease Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Israel Gastroesophageal Reflux Disease Market Revenues & Volume, By Antacids, 2021- 2031F |
6.1.4 Israel Gastroesophageal Reflux Disease Market Revenues & Volume, By Proton Pump Inhibitors, 2021- 2031F |
6.1.5 Israel Gastroesophageal Reflux Disease Market Revenues & Volume, By H2 Receptor Blocker, 2021- 2031F |
6.1.6 Israel Gastroesophageal Reflux Disease Market Revenues & Volume, By Pro Kinetic Agents, 2021- 2031F |
6.1.7 Israel Gastroesophageal Reflux Disease Market Revenues & Volume, By Dopamine Receptor Antagonist, 2021- 2031F |
6.1.8 Israel Gastroesophageal Reflux Disease Market Revenues & Volume, By Endocinch, 2021- 2031F |
6.2 Israel Gastroesophageal Reflux Disease Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Israel Gastroesophageal Reflux Disease Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.2.3 Israel Gastroesophageal Reflux Disease Market Revenues & Volume, By Drug Stores, 2021- 2031F |
6.2.4 Israel Gastroesophageal Reflux Disease Market Revenues & Volume, By General Stores, 2021- 2031F |
6.2.5 Israel Gastroesophageal Reflux Disease Market Revenues & Volume, By Supermarkets, 2021- 2031F |
7 Israel Gastroesophageal Reflux Disease Market Import-Export Trade Statistics |
7.1 Israel Gastroesophageal Reflux Disease Market Export to Major Countries |
7.2 Israel Gastroesophageal Reflux Disease Market Imports from Major Countries |
8 Israel Gastroesophageal Reflux Disease Market Key Performance Indicators |
8.1 Average waiting time for GERD diagnosis and treatment |
8.2 Patient satisfaction with GERD management services |
8.3 Percentage of GERD patients utilizing non-pharmacological treatment options |
9 Israel Gastroesophageal Reflux Disease Market - Opportunity Assessment |
9.1 Israel Gastroesophageal Reflux Disease Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Israel Gastroesophageal Reflux Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Gastroesophageal Reflux Disease Market - Competitive Landscape |
10.1 Israel Gastroesophageal Reflux Disease Market Revenue Share, By Companies, 2024 |
10.2 Israel Gastroesophageal Reflux Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |